The effect of butyrate, a natural bacterial product of colonic bacterial flora, on nitric oxide (NO) production in murine vascular endothelial cell line END-D in response to IFN-g and/or LPS was studied. Butyrate significantly augmented NO production in END-D cells in response to IFN-g or IFN-g + LPS, but not LPS alone. The NO production was augmented by the addition of butyrate until 6 h after the stimulation with IFN-g or IFN-g + LPS. The augmentation was abolished by the removal of butyrate from the cultures. Butyrate enhanced the expression of inducible type NO synthase (iNOS) in the stimulated END-D cells. Furthermore, butyrate-enhanced NO production in the presence of various signal inhibitors down-regulating the signal pathways using nuclear factor (NF)-kB, mitogen-activated protein (MAP) kinases and Janus tyrosine kinase. The putative mechanism of butyrate-induced augmentation of NO production in response to IFN-g or IFN-g + LPS is discussed.
INTRODUCTION
Butyrate is a short-chain fatty acid derived from the metabolism of intestinal contents by gut bacteria and is present in normal large intestines at a concentration range of 5-24 mM. 1 However, in conditions like inflammatory bowel diseases, the level of butyrate seems to be elevated. 2, 3 Bioactive butyrate has been shown to modulate various immune functions of the host, such as enhancement of enzyme activities, 4 production of prostaglandin 5 and gene expression of pro-inflammatory mediators. [6] [7] [8] Moreover, butyrate is suggested to collaborate with bacterial lipopolysaccharide (LPS) in modulating immune functions of the host. 5 Butyrate synergistically acts with LPS to induce the production of pro-inflammatory cytokines and mediators. 6, 9, 10 Previously, we reported that butyrate down-regulated LPS-induced nitric oxide (NO) production in RAW264.7 mouse macrophage cells through preventing the expression of inducible-type NO synthase (iNOS) proteins, and that it was due to the inhibitory action of butyrate on the activation of nuclear factor (NF)-kB. 6 Recently, we have established NO production in vascular endothelial cells treated with gamma interferon (IFN-g) or the combination of IFN-g and LPS. 11 In the present study, we investigated the effect of butyrate on NO production in the mouse vascular endothelial cell line END-D in response to IFN-g, LPS or IFN-g + LPS.
Here we describe that butyrate augments NO production in END-D cells treated with IFN-g or IFN-g + LPS.
MATERIALS AND METHODS

Materials
Murine recombinant gamma interferon (IFN-g) was purchased from R&D Systems (Minneapolis, MN, USA). LPS from Escherichia coli O55:B5 and sodium butyrate was obtained from Sigma Chemical Co. (St Louis, MO, USA). LPS and sodium butyrate were dissolved at 1 mg/ml and 100 mM in distilled water, respectively. They were further diluted in the culture medium for experiments. SB202190, SB202474, PD98059, AG490, 5-nitro-2-(3-phenylpropylamino)benzoic acid and pyrrolidine dithiocarbamate were purchased from Calbiochem (Darmstadt, Germany).
Cell culture
The murine vascular endothelial cell line END-D was maintained in RPMI 1640 medium (Sigma) containing 5% heat-inactivated fetal calf serum (Gibco-BRL, Grand Island, NY, USA) at 37°C with 5% CO 2 . The cells were washed gently with Hank's balanced salt solution (Sigma) and scraped from the dishes. The cells were counted and seeded in a 96-well or 12-well plates.
Determination of nitrite concentration
Nitrite as the end product of NO was measured by using the Griess reagent as described elsewhere. 12 Culture supernatants (50 ml) were mixed with 100 ml of the Griess reagent, and the nitrite concentration in the culture supernatant was measured 10 min after mixing at an absorbance of 540 nm. The nitrite concentration was determined with reference to a standard curve using sodium nitrite. All data represent the mean of triplicates ± SD from four experiments.
Immunoblotting END-D cells were cultured with IFN-g (20 ng) or IFN-g + LPS (1 mg) in the presence or absence of butyrate (1 mM) in 35-mm culture dishes (4 x 10 5 cells/dish). The cells were suspended directly in a lysis buffer and boiled for 5 min at 100°C. 6 The protein concentration of the samples was measured using a BCA protein assay (Pierce, Rockford, IL, USA). Cell lysates containing an equal amount of protein (20 mg/lane) were loaded onto a 4-20% gradient gel, run under reducing conditions, and transferred to the membrane. The membranes were treated with 0.5% skimmed milk for 1 h, rinsed and incubated with a 1:2000 dilution of rabbit anti-iNOS antibody (Upstate Biotechnology, Lake Placid, NY, USA). The blots were further treated with a 1:5000 dilution of peroxidase-conjugated goat anti-rabbit Ig antibody for 30 min. The immune complex on the blots was detected with enhanced chemiluminescence substrate (New England Nuclear, Boston, MA, USA).
Statistical analysis
Experimental results are expressed as the mean ± SD. Statistical significance was determined by Student's t-test.
RESULTS
Effect of butyrate on NO production in END-D cells stimulated with IFN-g, LPS or IFN-g + LPS
The effect of butyrate on NO production in END-D cells treated with IFN-g (20 ng/ml), LPS (1 mg/ml) or IFN-g + LPS was studied. The nitrite concentration was measured in the cultures of END-D cells stimulated with IFN-g, LPS or IFN-g + LPS for 48 h in the presence or absence of butyrate ( Fig. 1 ). Butyrate at 1 mM enhanced NO production in END-D cells treated with IFN-g or IFN-g + LPS, but not in those treated with LPS alone. A low concentration (0.1 mM) of butyrate did not augment NO production. Butyrate at 0.1 and 1 mM did not affect the NO production and cell growth of END-D cells. Butyrate at higher than 10 mM exhibited a cytotoxic action on END-D cells.
Effect of pre-and post-treatment of butyrate on NO production in END-D cells stimulated with IFN-g, LPS or IFN-g + LPS
The effect of pre-and post-treatment of butyrate on NO production was studied by adding butyrate at various Fig. 1 . Effect of butyrate on NO production in END-D cells stimulated with LPS, IFN-g, or IFN-g + LPS. END-D cells were cultured with IFN-g (20 ng/ml), LPS (1 mg/ml) or IFN-g + LPS for 48 h in the presence of 0.1 or 1 mM butyrate. The nitrite concentration in the culture supernatant was determined for NO production. One of three independent experiments is shown. *P < 0.01 versus butyrate (0) group. times before and after the treatment with IFN-g or IFN-g + LPS (Fig. 2 ). The nitrite concentration was determined 48 h after stimulation with IFN-g or IFN-g + LPS. Pretreatment with butyrate for 6 h and 24 h clearly enhanced NO production in END-D cells stimulated with IFN-g or IFN-g + LPS. Further, the addition of butyrate 6 h after stimulation also augmented NO production and the augmentation was almost the same as with simultaneous treatment of butyrate. The addition of butyrate 24 h after the stimulation was still effective for the enhancement of NO production, although the enhancement was much less. However, the addition of butyrate 42 h after stimulation did not enhanced it.
Effect of removal of butyrate on butyrate-induced enhancement of NO production
We examined whether the continuous presence of butyrate in the culture was required for the enhancement of NO production. END-D cells were pretreated with butyrate for 16 h, and then butyrate was removed by washing. The cells were further stimulated with IFN-g or IFN-g + LPS for 48 h. The removal of butyrate definitely abolished the augmentation of NO production in stimulated END-D cells (Fig. 3) .
Effect of butyrate on the expression of iNOS proteins in END-D cells stimulated with IFN-g or IFN-g + LPS
The iNOS expression in END-D cells was examined by the immunoblotting method using anti-iNOS antibody. END-D cells were stimulated with IFN-g or IFN-g + LPS for 24 h in the presence of butyrate (1 mM). As shown in Figure 4 , immunoblotting analysis demonstrated that butyrate clearly augmented the expression of iNOS proteins with a molecular weight of 130 kDa in END-D cells.
Mechanism of butyrate-induced enhancement of NO production in IFN-g or IFN-g + LPS-stimulated END-D cells
Previously, we reported that butyrate down-regulated LPS-induced NO production in RAW 264.7 macrophage Butyrate-enhanced NO production 35 Fig. 2 . Effect of pre-and post-treatment of butyrate on NO production in END-D cells stimulated with LPS, IFN-g, or IFN-g + LPS. END-D cells were cultured with IFN-g (20 ng/ml), LPS (1 mg/ml) or IFN-g + LPS, followed by addition of 1 mM butyrate at various times before and after the stimulation. The nitrite concentration in the culture supernatant 48 h after the stimulation was determined for NO production. One of three independent experiments is shown. *P < <0.01 versus none group. Fig. 3 . Effect of removal of butyrate on butyrate-induced enhancement of NO production. END-D cells were pretreated with butyrate for 16 h, and then washed for the removal of butyrate. The cells were stimulated with IFN-g or IFN-g + LPS for 48 h. The nitrite concentration in the culture supernatant 48 h after the stimulation was determined for NO production. One of three independent experiments is shown. *P < <0.01 versus no washing group. cells through preventing the activation of NF-kB. 6 We examined the possibility that butyrate might augment NO production in END-D cells through activating the signal pathways. The effect of a series of signal inhibitors on butyrate-induced enhancement of NO production in END-D cells stimulated with IFN-g or IFN-g + LPS was studied. SB203580 (10 mM), a p38 inhibitor, and PD98059 (10 mM), an ERK1/2 inhibitor, reduced NO production in stimulated END-D cells but did not abolish butyrate-induced enhancement of NO production. Further, 5-nitro-2-(3-phenylpropylamino)benzoic acid (100 mM), an ERK1/2 and SAPK/JNK inhibitor, pyrrolidine dithiocarbamate (100 mM), a NF-kB inhibitor, AG490 (10 mM), a JAK2 inhibitor, and genistein (25 mM), a tyrosine kinase inhibitor, did not inhibit butyrate-induced augmentation of NO production. In addition, butyrate did not augment the phosphorylation of signal molecules in a series of MAP kinases and NF-kB (data not shown).
Butyrate is an inhibitor of histone deacetylases 13, 14 and is reported to play a role in the augmented responsiveness of mouse B cells to LPS by butyrate. 15, 16 Therefore, the effect of butyrate on the acetylation of histone in END-D cells was examined with immunohistochemical 36 Morikawa, Sugiyama, Koide et al. Fig. 4 . Effect of butyrate on the expression of iNOS proteins in END-D cells stimulated with IFN-g or IFN-g + LPS. END-D cells were stimulated with IFN-g or IFN-g + LPS for 24 h in the presence of butyrate (1 mM). The iNOS expression in these cells was analyzed by the immunoblotting method using rabbit anti-iNOS antibody. One of four independent experiments is shown. Lane 1, butyrate; 2, IFN-g 100 ng; 3, IFN-g 100 ng + butyrate; 4, IFN-g 20 ng + LPS 1 mg/ml; 5, IFN-g 20 ng + LPS + butyrate. staining using anti-acetyl-histone H3 antibody (Fig. 5 ). END-D cells were cultured with IFN-g + LPS in the presence and absence of butyrate (1 mM) for 24 h, fixed and stained. The immunohistochemical analysis showed that there was no significant difference in the expression of acetyl-histone H3 between untreated and butyratepretreated END-D cells in the stimulation with IFN-g or IFN-g and LPS.
DISCUSSION
In the present study, we demonstrated that butyrate enhanced NO production in mouse vascular endothelial END-D cells stimulated with IFN-g or IFN-g + LPS via augmented iNOS expression. Previously, we reported that butyrate down-regulated LPS-induced NO production in RAW264.7 macrophage cells by preventing iNOS expression. 6 Therefore, butyrate appeared to exhibit a contradictory action on macrophages and vascular endothelial cells in NO production. In RAW264.7 macrophage cells, butyrate inhibits the activation of NF-kB. 6 In END-D cells, however, butyrate was unlikely to affect the signal pathways including NF-kB, p38, ERK1/2 and SAPK/JNK in the enhancement of NO production. The mechanism of butyrate-induced augmentation of iNOS expression is still a matter for speculation.
There are several reports on the enhancing effect of butyrate on the cell function of various cell types. 7, [17] [18] [19] Butyrate is an inhibitor of histone deacetylases 13, 14 and causes histone hyperacetylation. 20, 21 In fact, histone acetylation was reported to play a role in the augmented responsiveness of mouse B cells to LPS by butyrate. 15, 16 Butyrate might exhibit an enhancing effect on NO production through histone hyperacetylation. The hypothetical idea might corresponded to our findings that the continuous presence of butyrate is necessary for the augmentation and that the 6 h post-treatment with butyrate is still effective for the augmentation of NO production. It was of particular interest to pursue the involvement of histone acetylation in butyrate-induced augmentation of NO production in response to IFN-g or IFN-g + LPS. However, the hypothetical idea could not be confirmed by immunohistochemical staining using anti-acetyl histone antibody. The possibility still remains that a small amount of acetylated histone induced by butyrate could not be detected by immunohistochemical staining.
Butyrate, a metabolite derived from bacteria, augmented NO production in mouse vascular endothelial cells but down-regulated it in mouse macrophages, suggesting the differential regulation of NO production between macrophages and vascular endothelial cells. Previously, we demonstrated that butyrate inhibited LPS-induced NO production in macrophages through the down-regulation of NF-kB activation. 6 NF-kB was not activated in vascular endothelial cells stimulated with IFN-g + LPS. The failure of NF-kB activation in vascular endothelial cells might be related to butyrateinduced augmentation of NO production. In the preceding paper, we hypothesized that butyrate might down-regulate the production of cytotoxic NO by immune effector cells, such as macrophages, to escape from the protective mechanisms of the host. 6 The butyrate-induced augmentation of NO production in vascular endothelial cells might be involved in the protective immunity of the host as well as the hemodynamic effect. We speculate that butyrate carries information from bacteria to vascular endothelial cells.
